Skip to main content
. 2019 Oct 16;8:1039. Originally published 2019 Jul 10. [Version 2] doi: 10.12688/f1000research.19308.2

Figure 2. Treatment with IL-1 receptor antagonist (IL-1Ra) has no effect on complement components downregulated after stroke.

Figure 2.

Minimum concentrations of ( A) C3b/ iC3b, ( B) C3, ( C) C4, ( D) Factor H and ( E) Properdin were measured in the first seven days after stroke were reduced in both placebo and IL-1Ra treated patients in comparison to healthy controls. Data show mean ±SD, * P<0.05; ** P<0.01; one-way ANOVA with Bonferonni correction.